<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The lysosomal protease Cathepsin D (CD) has been implicated in the homeostasis of lymphatic tissues </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated whether the level of CD expression influences the progression and the clinical outcome in Non-Hodgkin's <z:hpo ids='HP_0002665'>Lymphomas</z:hpo> (NHLs) </plain></SENT>
<SENT sid="2" pm="."><plain>The expression of CD was assessed by immunohistochemistry and immunofluorescence in biopsies of Diffuse Large B Cell <z:hpo ids='HP_0002665'>Lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, 35 cases), Follicular <z:hpo ids='HP_0002665'>Lymphomas</z:hpo> (FL, 9 cases of grade I-II plus 14 cases of grade IIIB), <z:hpo ids='HP_0011010'>Chronic</z:hpo> Lymphocytic <z:mpath ids='MPATH_336'>Leukaemias</z:mpath> (CLL, 17 cases) and Peripheral T-cell <z:hpo ids='HP_0002665'>Lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTCL</z:e>, 5 cases) </plain></SENT>
<SENT sid="3" pm="."><plain>CD staining showed a cytoplasmic punctate pattern compatible with its lysosomal localization </plain></SENT>
<SENT sid="4" pm="."><plain>Based on the level of CD expression and the proportion of positive cells, <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were classified as 'low expressing' (&lt; 20% of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells) or 'highly expressing' (&gt;or= 20% of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0002665'>Lymphomas</z:hpo> highly expressing CD were associated with a worse stage (III-IV) at diagnosis (31/34 cases; p=0.002) and with a poor clinical outcome (i.e., partial remission and <z:hpo ids='HP_0011420'>death</z:hpo>; 28/34 cases; p=0.03) </plain></SENT>
<SENT sid="6" pm="."><plain>In the subgroup of aggressive/high grade of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (i.e., <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, FL IIIB and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTCL</z:e>), the Kaplan-Meier curve revealed a very low cumulative overall survival probability (approximately 20% at 5 year) for patients bearing a NHL with &gt; 40% CD-positive cells compared to that of patients bearing a NHL with &lt; 20% CD-positive cells ( approximately 70% at 5 year) </plain></SENT>
<SENT sid="7" pm="."><plain>This correlation was statistically significant (log-rank test, p=0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>In Cox multivariate analysis CD failed to be a prognosticator independent of pathologic stage, though the hazard ratio confirmed the association of low expression with a better survival probability </plain></SENT>
<SENT sid="9" pm="."><plain>These data indicate that the presence of a high percentage of CD-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells negatively reflects on the progression of NHLs </plain></SENT>
</text></document>